In a report released on January 30, Daina Graybosch from Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research ...

bubbling under hot 100 the week’s most popular current songs across all genres below no. 100, ranked by streaming activity data by online music sources tracked by luminate, radio airplay ...

The best camera under $100 will enable you to capture some amazing memories on a budget and you'll be amazed at what you can get for your money Investing in the best camera under $100 is a ...

Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target to $119.00. Discover outperforming stocks and invest ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...

In separate presentations, the CEOs of Bristol Myers Squibb, Pfizer and Merck laid out their plans to overcome high-profile losses of exclusivity (LOEs) slated to dent sales through the end of the ...

Merck & Co. expects to launch an easier-to-administer version of its blockbuster cancer treatment Keytruda before the end of the year, accelerating the company’s efforts to protect its top ...

Executives at Amgen made the case for MariTide’s differentiation, while Merck’s CEO contended that Keytruda’s coming loss of exclusivity can be managed. SAN FRANCISCO — For any hopes the dealmaking ...

21 × 10 = 210 When you multiply by 100, move all the digits two places to the left, putting a zero in the empty spaces.

Summit Therapeutics (NASDAQ:SMMT), a drug developer challenging pharma giant Merck's (NYSE:MRK) dominance in lung cancer, won a new buy recommendation from Truist on Wednesday based on its deal ...

WuXi 2269-0.22%decrease; red down pointing triangle Biologics agreed to sell an overseas vaccine facility to Merck MRK-0.50%decrease; red down pointing triangle & Co. for half a billion dollars ...